Evidence map›Paper›PMID 22412148›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2012

Fatigue, inflammation, and ω-3 and ω-6 fatty acid intake among breast cancer survivors.

Catherine M Alfano, Ikuyo Imayama, Marian L Neuhouser, Janice K Kiecolt-Glaser, Ashley Wilder Smith, Kathleen Meeske, Anne McTiernan, Leslie Bernstein, Kathy B Baumgartner, Cornelia M Ulrich and 1 more

Open access · bronzeAbstract readComparative StudyMulticenter Study
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 6 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 6 syntheses or guidelines pooled it, 148 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Interventions for multidimensional aspects of breast cancer-related fatigue: a meta-analytic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Pooled it
  4. Pooled it
  5. The biology of cancer-related fatigue: a review of the literature.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2015
    Pooled it
  6. Survivorship: fatigue, version 1.2014.Journal of the National Comprehensive Cancer Network : JNCCN · 2014
    Guideline
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Catherine M AlfanoOffice of Cancer Survivorship, National Cancer Institute, 6116 Executive Blvd, Ste 404, Bethesda, MD 20892-8336, USA. alfanoc@mail.nih.gov
Ikuyo Imayama
Marian L Neuhouser
Janice K Kiecolt-Glaser
Ashley Wilder Smith
Kathleen Meeske
Anne McTiernan
Leslie Bernstein
Kathy B Baumgartner
Cornelia M Ulrich
Rachel Ballard-Barbash
University of Washington · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Thomas James Lynch · 1985 to 2026
$296.4M
UNM HSC Clinical and Translational Science CenterUL1TR001449 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CAMPEN, MATTHEW J, PANDHI, NANCY · 2015 to 2024
$36.9M
ZIPRASIDONE IN NORMAL HEPATIC FUNCTION SUBJECTS &IN HEPATIC DYSFUCTIN SUBJECTSM01RR000037 · NCRR · UNIVERSITY OF WASHINGTON · PI GIBSON, RONALD L · 1985 to 2007
$33.8M
ZUNI KIDNEY PROJECT STUDY I--POPULATION BASED SURVEY OF RENAL DISEASEM01RR000997 · NCRR · UNIVERSITY OF NEW MEXICO · PI LARSON, RICHARD S · 1985 to 2010
$30.0M
University of New Mexico Clinical and Translational Science CenterUL1TR000041 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI LARSON, RICHARD S · 2012 to 2014
$9.8M
Fatigue, Depression, and Inflammation in Cancer Survivors: A Prospective StudyR01CA131029 · NCI · OHIO STATE UNIVERSITY · PI KIECOLT-GLASER, JANICE · 2008 to 2013
$4.1M
SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAMN01PC067010 · PC · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ROSS, RONALD K · 1996 to 2000
$2.4M
SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTSN01CN005228 · CN · UNIVERSITY OF NEW MEXICO · PI KEY, CHARLES · 1990 to 1996
–
NCATS NIH HHS UL1 TR000041NCATS NIH HHS UL1 TR001449NCI NIH HHS CA131029.NCI NIH HHS N01 CN005228NCI NIH HHS N01-CN-05228NCI NIH HHS N01-CN-75036-20NCI NIH HHS N01 PC067010NCI NIH HHS P30 CA015704NCI NIH HHS R01 CA131029NCRR NIH HHS M01 RR000037NCRR NIH HHS M01-RR-00037NCRR NIH HHS M01 RR000997NCRR NIH HHS M01-RR-0997
6 · The paper itself

Abstract

purposeEvidence suggests that inflammation may drive fatigue in cancer survivors. Research in healthy populations has shown reduced inflammation with higher dietary intake of ω-3 polyunsaturated fatty acids (PUFAs), which could potentially reduce fatigue. This study investigated fatigue, inflammation, and intake of ω-3 and ω-6 PUFAs among breast cancer survivors.

methodsSix hundred thirty-three survivors (mean age, 56 years; stage I to IIIA) participating in the Health, Eating, Activity, and Lifestyle Study completed a food frequency/dietary supplement questionnaire and provided a blood sample assayed for C-reactive protein (CRP) and serum amyloid A (30 months after diagnosis) and completed the Piper Fatigue Scale and Short Form-36 (SF-36) vitality scale (39 months after diagnosis). Analysis of covariance and logistic regression models tested relationships between inflammation and fatigue, inflammation and ω-3 and ω-6 PUFA intake, and PUFA intake and fatigue, controlling for three incremental levels of confounders. Fatigue was analyzed continuously (Piper scales) and dichotomously (SF-36 vitality ≤ 50).

resultsBehavioral (P = .003) and sensory (P = .001) fatigue scale scores were higher by increasing CRP tertile; relationships were attenuated after adjustment for medication use and comorbidity. Survivors with high CRP had 1.8 times greater odds of fatigue after full adjustment (P < .05). Higher intake of ω-6 relative to ω-3 PUFAs was associated with greater CRP (P = .01 after full adjustment) and greater odds of fatigue (odds ratio, 2.6 for the highest v lowest intake; P < .05).

conclusionResults link higher intake of ω-3 PUFAs, decreased inflammation, and decreased physical aspects of fatigue. Future studies should test whether ω-3 supplementation may reduce fatigue among significantly fatigued breast cancer survivors.

Indexed as

Dietary SupplementsAdultAgedAnalysis of VarianceBreast NeoplasmsCarcinoma, Intraductal, NoninfiltratingCohort StudiesC-Reactive ProteinFatigueFatty Acids, Omega-3Fatty Acids, Omega-6FemaleFollow-Up StudiesHumansInflammationInflammation MediatorsC-Reactive ProteinFatty Acids, Omega-3Fatty Acids, Omega-6Inflammation MediatorsSerum Amyloid A Protein

Identifiers

PMID22412148
PMCPMC3341143
OpenAlexW2123963828

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.